BOLT - Bolt Biotherapeutics, Inc.
0.348
0.002 0.546%
Share volume: 211,346
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$0.35
0.00
0.01%
View ratios
| Fiscal Date | 12-31-2024 | |
|---|---|---|
| Fiscal Quarter | Q4 2024 | |
| Report Date | 03-24-2025 | |
| Total revenue | 0.000 | |
| Cost of revenue | 0.000 | |
| Gross profit | 0.000 | |
| Operating expenses | 15.669 M | |
| Selling general and admin | 3.947 M | |
| Research and development | 11.722 M | |
| Total expenses | 16.916 M | |
| Operating income | -16.916 M | |
| Ebit | -16.916 M | |
| Pretax income | -15.936 M | |
| Income tax | 0.000 | |
| Net income basic | 0.000 | |
| Net income | -15.936 M | |
